Publication

Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures

Pinzon, N. E., Breve, J. J. P., Bol, J. G. J. M., Drukarch, B., Baron, W. & van Dam, A-M., 28-Dec-2017, In : Journal of neuroinflammation. 14, 13 p., 260.

Research output: Contribution to journalArticleAcademicpeer-review

  • Nathaly Espitia Pinzon
  • John J. P. Breve
  • John G. J. M. Bol
  • Benjamin Drukarch
  • Wia Baron
  • Anne-Marie van Dam

Background: During multiple sclerosis (MS) lesion formation, inflammatory mediators are produced by microglial cells and invading leukocytes. Subsequently, hypertrophic astrocytes fill the lesion and produce extracellular matrix (ECM) proteins that together form the astroglial scar. This is beneficial because it seals off the site of central nervous system (CNS) damage. However, astroglial scarring also forms an obstacle that inhibits remyelination of brain lesions. This is possibly an important cause for incomplete remyelination of the CNS in early stage MS patients and for failure of remyelination when the disease progresses. Tissue transglutaminase (TG2), a Ca2+-dependent enzyme that can cross-link proteins, appears in astrocytes in inflammatory MS lesions and may contribute to the rearrangement of ECM protein deposition and aggregation.

Methods: The effect of different inflammatory mediators on TG2 and fibronectin, an ECM protein, protein levels was examined in primary rat microglia and astrocytes by western blotting. Also, TG2 activity was analyzed in primary rat astrocytes by a TG activity assay. To determine the role of TG2 in the deposition and cross-linking of fibronectin, a TG2 inhibitor and TG2 knockdown astrocytes were used.

Results: Our data show that under inflammatory conditions in vitro, TG2 production is enhanced in astrocytes and microglia. We observed that in particular, astrocytes produce fibronectin that can be cross-linked and aggregated by exogenous TG2. Moreover, inflammatory stimulus-induced endogenously produced TG2 is involved in the appearance of morphological fibril-like fibronectin deposits but does not lead to cross-linked fibronectin aggregates.

Conclusions: Our in vitro observations suggest that during MS lesion formation, when inflammatory mediators are produced, astrocyte-derived TG2 may contribute to ECM rearrangement, and subsequent astroglial scarring.

Original languageEnglish
Article number260
Number of pages13
JournalJournal of neuroinflammation
Volume14
Publication statusPublished - 28-Dec-2017

    Keywords

  • Tissue transglutaminase, Neuroinflammation, Astrocytes, Astroglial scarring, Extracellular matrix, Fibronectin, MULTIPLE-SCLEROSIS LESIONS, CHONDROITIN SULFATE PROTEOGLYCANS, OLIGODENDROCYTE PROGENITOR MATURATION, CENTRAL-NERVOUS-SYSTEM, EXTRACELLULAR-MATRIX, CROSS-LINKING, CELL-ADHESION, DEMYELINATED LESIONS, GROWTH-FACTOR, CNS INJURY

Download statistics

No data available

ID: 52134487